The Whittier Institute for Diabetes
About Us What is Diabetes? Patient Programs In the Lab Clinical Trials Ways of Giving Making News Contact Us Mobile Medical Unit

 

Principal Investigators

Principal Investigators


Principal Investigators

The internationally recognized roster of Principal Investigators and their respective work has placed the Research Program among the world’s leading diabetes research efforts.

    • Alberto Hayek, M.D.
    • Vincenzo Cirulli, M.D., Ph.D.
    • Ulupi Jhala, Ph.D.
    • Charles King, Ph.D.

    • Alberto Hayek, M.D., Professor of Pediatrics and Director, Islet Cell Research Laboratory, is engaged in studies with human islets and human embryonic stem cells in efforts to develop a cell-based treatment, islet transplantation, for patients with type 1 diabetes. Although still a research procedure, one of islet transplantation’s significant obstacles to benefiting more patients is the limited pancreases available. Dr. Hayek’s lab is actively working on replicating cells in order to increase the potential pool of human recipients. ahayek@ucsd.edu

    • Vincenzo Cirulli, M.D., Ph.D., Associate Professor, is studying mechanisms by which cell adhesion molecules regulate the development and maturation of insulin-producing cells (beta-cells) in the pancreas. Ultimately, his team's goal is to define molecular pathways that can be manipulated to generate new insulin-secreting cells and/or expand the limited number of these cells available for transplantation. vcirulli@ucsd.edu

    • Ulupi Jhala, Ph.D., Research Assistant Professor, is examining the molecular mechanisms by which pancreatic beta cell enriched proteins called transcription factors, respond to external signals such as glucose for insulin gene regulation. Also being examined is the role of these same proteins in the development and differentiation of insulin secreting beta cells. ujhala@ucsd.edu

    • Charles King, Ph.D., Assistant Research Associate, is trying to generate insulin producing, glucose responsive beta cells from either pancreatic progenitor cells or human embryonic stem cells for human transplantation to treat type 1 diabetes. His team uses a combination of two dimensional electrophoresis and mass spectrometry to map and identify global changes in protein expression patterns and monitor the role of specific signal transduction pathways during cellular differentiation. chking@ucsd.edu

      We graciously thank our Community Partners in their support with Research at the Whittier Institute 

    • Hillblom Foundation

    • Juvenile Diabetes Research Foundation

    • University of California San Diego, Department of Pediatrics